STOCK TITAN

[Form 4] Delek US Holdings, Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Soreq Avigal, President & CEO and Director of Delek US Holdings, Inc. (DK), reported a transaction dated 09/10/2025 showing 7,768 shares of common stock disposed of at a price of $29.71 per share. The filing explains these shares were withheld for tax purposes upon vesting of equity awards, not sold on the open market. Following the withholding, Avigal beneficially owns 193,519 shares, held directly. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 09/12/2025. The filing is a routine insider reporting of compensation-related withholding rather than an active sale.

Soreq Avigal, Presidente e CEO e Direttore di Delek US Holdings, Inc. (DK), ha riportato una operazione datata 09/10/2025 che mostra 7.768 azioni ordinarie vendute al prezzo di $29,71 per azione. La dichiarazione spiega che tali azioni sono state retenute per motivi fiscali al vesting dei premi azionari, e non vendute sul mercato aperto. Dopo la trattenuta, Avigal detiene beneficialmente 193.519 azioni, detenute direttamente. Il Modulo 4 è stato firmato per conto della persona indicata dall'avvocato-in-fatto il 12/09/2025. La dichiarazione è una normale segnalazione di insider relativa alle trattenute legate alla retribuzione, anziché una vendita attiva.

Soreq Avigal, Presidente y CEO y Director de Delek US Holdings, Inc. (DK), informó una operación con fecha 09/10/2025 que mostró 7.768 acciones ordinarias transmitidas a un precio de $29,71 por acción. La presentación explica que estas acciones fueron retenidas por motivos fiscales al vesting de premios en acciones, no vendidas en el mercado abierto. Tras la retención, Avigal posee de forma beneficiosa 193.519 acciones, directamente. El Formulario 4 fue firmado en nombre de la persona reportada por un apoderado el 12/09/2025. La presentación es un reporte rutinario de insider sobre retenciones relacionadas con la compensación, más que una venta activa.

Soreq Avigal 사장은 Delek US Holdings, Inc. (DK)의 회장 겸 CEO이자 이사로, 2025년 9월 10일자로 거래를 보고했습니다. 이 거래는 주당 $29.71의 가격으로 7,768주의 보통주를 처분한 것을 보여줍니다. 공시는 이 주식이 공개 시장에서 팔린 것이 아니라 주식 보상 vesting에 따른 세금 목적의 원천징수로 보유된 것임을 설명합니다. 원천징수 후 Avigal은 193,519주의 주식을 직접 보유합니다. Form 4는 보고 대상자 대신 대리인이 2025년 9월 12일에 서명했습니다. 이 공시는 보상 관련 원천징수에 대한 일반적인 내부자 보고이며 적극적 매매는 아닙니다.

Soreq Avigal, Président et CEO et Directeur de Delek US Holdings, Inc. (DK), a signalé une opération datée du 10/09/2025 affichant 7 768 actions ordinaires cédées à un prix de $29,71 par action. Le dépôt précise que ces actions ont été retenues à des fins fiscales lors du vesting des attribution d'actions, et non vendues sur le marché libre. Après la retenue, Avigal possède bénéfi­ci­airement 193 519 actions, détenues directement. Le Formulaire 4 a été signé au nom de la personne visée par un mandataire le 12/09/2025. Le dépôt constitue un reporting intérieur de routine relatif à des retenues liées à la rémunération, et non une vente active.

Soreq Avigal, Präsidentin und CEO sowie Direktorin von Delek US Holdings, Inc. (DK), meldete eine Transaktion mit Datum 10.09.2025, bei der 7.768 Stammaktien zu einem Preis von $29,71 pro Aktie veräußert wurden. Die Einreichung erklärt, dass diese Aktien zur Steuerzwecken bei der Vesting von Aktienprämien einbehalten und nicht am offenen Markt verkauft wurden. Nach der Einbehaltung besitzt Avigal beneficial 193.519 Aktien, direkt gehalten. Das Formular 4 wurde im Namen der meldenden Person von einem Bevollmächtigten am 12.09.2025 unterzeichnet. Die Einreichung ist ein routinemäßiger Insider-Bericht über gehaltbezogene Einbehalte und kein aktiver Verkauf.

سوريك أفيغال، رئيسة ومديرة تنفيذية وعضو مجلس إدارة Delek US Holdings, Inc. (DK)، أفادت عن صفقة بتاريخ 09/10/2025 تُظهر 7,768 سهماً عادياً جرى التصرف بها بسعر $29.71 للسهم الواحد. تشرح الوثيقة أن هذه الأسهم تم حجزها لأغراض ضريبية عند vesting المكافآت الأسهم، وليست مباعة في السوق المفتوح. بعد الحجز، تمتلك أفيغال فعلياً 193,519 سهماً، مُلْقاة بشكل مباشر. تم توقيع النموذج 4 نيابة عن الشخص المبلغ من قِبل وكيل فِعلي في تاريخ 12/09/2025. الإيداع هو تقرير داخلي اعتيادي عن الحجز المرتبط بالتعويض، وليس بيعا نشطا.

Soreq AvigalDelek US Holdings, Inc. (DK) 的总裁兼首席执行官及董事,报告了一笔日期为2025/09/10的交易,显示以每股$29.71的价格處置了7,768股普通股。文件说明这些股票是为了税务目的在股权奖励归属时被扣缴,而非在公开市场出售。扣缴后,Avigal直接持有有效的193,519股股票。Form 4由代为报告人之代理人在2025/09/12签署。该文件属于常规的内部人报告,关于与酬金相关的扣缴,而非主动出售。

Positive
  • Withholding indicates retention of underlying equity award rather than an open-market sale, preserving insider alignment
  • Transaction is routine and properly reported via Form 4, signed by attorney-in-fact, showing governance/compliance processes
Negative
  • Direct holdings decreased by 7,768 shares due to tax withholding, lowering the reported share count to 193,519

Insights

TL;DR: Routine tax-withholding for vested equity; modest reduction in direct shares, limited near-term market impact.

The transaction code and explanation indicate the 7,768 shares were withheld to satisfy tax obligations on vested awards, not sold into the market. At a reported price of $29.71, the withheld amount is administrative and reflects compensation realization rather than a decision to liquidate holdings. The post-transaction direct ownership of 193,519 shares remains material for insider alignment, but this single withholding event is not likely to be a material liquidity or signaling event for investors.

TL;DR: Filing reflects standard insider reporting and tax-withholding on equity awards; governance controls appear followed.

The Form 4 discloses withholding for taxes upon vesting, which is a common compliance step when equity awards vest. The report was executed by an attorney-in-fact, indicating administrative handling consistent with governance practices. There is no indication of unusual timing, accelerations, or external agreements affecting the transaction. As filed, this is a routine disclosure with no evident governance concerns.

Soreq Avigal, Presidente e CEO e Direttore di Delek US Holdings, Inc. (DK), ha riportato una operazione datata 09/10/2025 che mostra 7.768 azioni ordinarie vendute al prezzo di $29,71 per azione. La dichiarazione spiega che tali azioni sono state retenute per motivi fiscali al vesting dei premi azionari, e non vendute sul mercato aperto. Dopo la trattenuta, Avigal detiene beneficialmente 193.519 azioni, detenute direttamente. Il Modulo 4 è stato firmato per conto della persona indicata dall'avvocato-in-fatto il 12/09/2025. La dichiarazione è una normale segnalazione di insider relativa alle trattenute legate alla retribuzione, anziché una vendita attiva.

Soreq Avigal, Presidente y CEO y Director de Delek US Holdings, Inc. (DK), informó una operación con fecha 09/10/2025 que mostró 7.768 acciones ordinarias transmitidas a un precio de $29,71 por acción. La presentación explica que estas acciones fueron retenidas por motivos fiscales al vesting de premios en acciones, no vendidas en el mercado abierto. Tras la retención, Avigal posee de forma beneficiosa 193.519 acciones, directamente. El Formulario 4 fue firmado en nombre de la persona reportada por un apoderado el 12/09/2025. La presentación es un reporte rutinario de insider sobre retenciones relacionadas con la compensación, más que una venta activa.

Soreq Avigal 사장은 Delek US Holdings, Inc. (DK)의 회장 겸 CEO이자 이사로, 2025년 9월 10일자로 거래를 보고했습니다. 이 거래는 주당 $29.71의 가격으로 7,768주의 보통주를 처분한 것을 보여줍니다. 공시는 이 주식이 공개 시장에서 팔린 것이 아니라 주식 보상 vesting에 따른 세금 목적의 원천징수로 보유된 것임을 설명합니다. 원천징수 후 Avigal은 193,519주의 주식을 직접 보유합니다. Form 4는 보고 대상자 대신 대리인이 2025년 9월 12일에 서명했습니다. 이 공시는 보상 관련 원천징수에 대한 일반적인 내부자 보고이며 적극적 매매는 아닙니다.

Soreq Avigal, Président et CEO et Directeur de Delek US Holdings, Inc. (DK), a signalé une opération datée du 10/09/2025 affichant 7 768 actions ordinaires cédées à un prix de $29,71 par action. Le dépôt précise que ces actions ont été retenues à des fins fiscales lors du vesting des attribution d'actions, et non vendues sur le marché libre. Après la retenue, Avigal possède bénéfi­ci­airement 193 519 actions, détenues directement. Le Formulaire 4 a été signé au nom de la personne visée par un mandataire le 12/09/2025. Le dépôt constitue un reporting intérieur de routine relatif à des retenues liées à la rémunération, et non une vente active.

Soreq Avigal, Präsidentin und CEO sowie Direktorin von Delek US Holdings, Inc. (DK), meldete eine Transaktion mit Datum 10.09.2025, bei der 7.768 Stammaktien zu einem Preis von $29,71 pro Aktie veräußert wurden. Die Einreichung erklärt, dass diese Aktien zur Steuerzwecken bei der Vesting von Aktienprämien einbehalten und nicht am offenen Markt verkauft wurden. Nach der Einbehaltung besitzt Avigal beneficial 193.519 Aktien, direkt gehalten. Das Formular 4 wurde im Namen der meldenden Person von einem Bevollmächtigten am 12.09.2025 unterzeichnet. Die Einreichung ist ein routinemäßiger Insider-Bericht über gehaltbezogene Einbehalte und kein aktiver Verkauf.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Soreq Avigal

(Last) (First) (Middle)
310 SEVEN SPRINGS WAY
SUITE 500

(Street)
BRENTWOOD TN 37027

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/10/2025 F(1) 7,768 D $29.71 193,519 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares withheld for tax purposes upon vesting of equity awards.
Remarks:
/s/ Misty Lavender, Attorney in Fact 09/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Delek US (DK) CEO Soreq Avigal report on the Form 4?

The Form 4 reports that on 09/10/2025 7,768 common shares were disposed of at $29.71 per share via withholding for tax purposes upon vesting of equity awards.

Why were shares "disposed of" on this Form 4 if they were withheld for taxes?

The filing explains the shares were withheld to satisfy tax obligations when equity awards vested, which is reported as a disposal even though it is not a market sale.

How many shares does Soreq Avigal beneficially own after the reported transaction?

The Form 4 shows a post-transaction direct beneficial ownership of 193,519 shares.

Who signed the Form 4 for the reporting person and when?

The Form 4 was signed by /s/ Misty Lavender, Attorney in Fact on 09/12/2025.

Does this Form 4 indicate an open-market sale by the CEO?

No. The filing specifies the shares were withheld for taxes upon vesting of awards, not sold on the open market.
Delek Us Hldgs Inc

NYSE:DK

DK Rankings

DK Latest News

DK Latest SEC Filings

DK Stock Data

1.79B
58.32M
2.97%
112.11%
11.72%
Oil & Gas Refining & Marketing
Petroleum Refining
Link
United States
BRENTWOOD